Tag «Community Acquired»

New Data Shows ZINFORO™ is More Effective Compared to Ceftriaxone in Adult Patients With Community Acquired Pneumonia in the Asian Region

BARCELONA, Spain, May 12, 2014 /PRNewswire/ — Phase III Data presented at 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) AstraZeneca has announced results from a Phase III comparator trial, which demonstrated ZINFORO™ (ceftaroline fosamil) 600mg twice daily is more effective compared to ceftriaxone 2g for treating Asian patients with community-acquired pneumonia (CAP). Results …